Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Innovid Announces Fourth Quarter 2023 Financial Results and Provides Guidance for Full Year

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Technology Quantum computing Stock Exchange
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Innovid, a leading provider of connected TV advertising solutions, announced their financial results for the fourth quarter of 2023 on February 27, 2024. The company reported a GAAP EPS of $(0.01), which was in line with analyst expectations. This marked a 66.67% increase in losses compared to the same period last year when EPS was $(0.03) per share.

Quarterly sales for Innovid were $38.62 million, surpassing analyst estimates by 6.68%. This represented a 14.60% increase over sales of $33.70 million in the fourth quarter of the previous year.

Looking ahead, Innovid provided financial guidance for the fourth quarter and full year of 2023:

– Q4 2023 revenue is expected to fall between $35 million and $37 million.
– Adjusted EBITDA for Q4 2023 is projected to range from $5.5 million to $7.5 million.
– Full year 2023 revenue is anticipated to be within the range of $136 million and $138 million.
– Adjusted EBITDA for the full year 2023 is forecasted to be between $16.6 million and $18.6 million, with an Adjusted EBITDA margin.

Norwegian Cruise Line Holdings (NCLH) Stock Price Sees Slight Decrease on February 27, 2024 with Positive Pre-Market Momentum

On February 27, 2024, Norwegian Cruise Line Holdings (NCLH) experienced a slight decrease in its stock price. According to data from CNN Money, NCLH is currently trading in the middle of its 52-week range and below its 200-day simple moving average. The price of NCLH shares dropped by $0.24 since the market last closed, representing a 1.48% decrease. The stock closed at $15.93 on the previous trading day.

Despite the slight decrease in price, there seems to be some positive momentum for NCLH as the stock has risen by $1.46 in pre-market trading. This increase indicates that investors may be feeling more optimistic about the company’s future prospects.

NCLH Stock Surges with Impressive Financial Results in 2024

On February 27, 2024, Norwegian Cruise Line Holdings (NCLH) stock showed strong performances as the company reported impressive financial results. According to data from CNN Money, NCLH’s total revenue for the past year was $4.84 billion, which represents a significant increase of 647.51% compared to the previous year. Additionally, the total revenue for the third quarter of the fiscal year was $2.54 billion, showing a 14.99% increase since the previous quarter.

The company’s net income also saw substantial growth, with a net loss of $2.27 billion for the past year. However, this figure represents a 49.63% improvement compared to the previous year. In the third quarter, NCLH reported a net income of $345.87 million, marking an impressive 301.63% increase since the previous quarter.

Furthermore, NCLH’s earnings per share (EPS) showed positive growth trends, with an EPS of -$5.41 for the past year. This figure represents a 56.15% increase compared to the previous year. In the third quarter, the company reported an EPS of $0.68, reflecting a remarkable 261.94% increase since the previous quarter.

Overall, NCLH’s financial performance on February 27, 2024, indicates a positive trajectory for the company. Investors may view these strong financial results as a positive indicator of NCLH’s resilience and potential for growth in the future.

Tags: NCLH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Markets and money

TG Therapeutics Granted Three New Patents for BRIUMVI in Treatment of Multiple Sclerosis

Title Appreciation for Minimum Postage Policy and Collaboration Standards

Biotechnology Markets and money

Verve Therapeutics Reports Impressive Q4 Financial Results

Recommended

NetApp Stock

NetApp Shares Face Diverging Outlooks Across Time Horizons

2 months ago

NRx Pharmaceuticals Finalizes Purchase Agreement for Unregistered Shares

2 years ago

Cather Precision Inc CEO Granted Authority to Acquire Company Shares in Vote of Confidence

2 years ago
Biglari Stock

The Biglari Holdings Enigma: A Tale of Two Investment Strategies

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

Can Skillsoft Stock Reverse Its Steep Decline?

Liquidmetal Shares: Technical Signals and Strategic Moves Hint at Potential Reversal

SunHydrogen Set for European Debut with Groundbreaking Technology

SuRo Capital’s Strategic Bet on AI and Crypto Fuels Investor Optimism

Oxford Lane Capital Receives Bullish Initiation with Significant Upside Potential

Trending

US Global Investors Stock
Analysis

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

by Felix Baarz
October 12, 2025
0

While gold prices continue their record-breaking ascent, shares of specialized fund manager US Global Investors have experienced...

FibroGen Stock

FibroGen Shares Extend Decline Amid Mixed Analyst Outlook

October 12, 2025
Adicet Bio Stock

Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

October 12, 2025
XpresSpa Group Stock

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

October 12, 2025
SkillsoftClass A Common Stock Stock

Can Skillsoft Stock Reverse Its Steep Decline?

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock
  • FibroGen Shares Extend Decline Amid Mixed Analyst Outlook
  • Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com